Loading...
01/10 16:15
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance with increased revenues, improved utilization, and a significant realized rate increase. Shareholder returns are robust with dividends and stock repurchases. The Q&A session reveals optimism in hiring and growth, with AI integration and proactive/reactive business strategies. Despite some uncertainties in regulatory environments and rate normalization, the overall sentiment is positive, driven by strong operational metrics and strategic initiatives.
Total Revenues Increased 8% to $147.1 million year-over-year. This growth was driven by demand for Exponent's risk management and asset integrity management services in the utility industry and disputes related to services in the energy, automotive, and medical device sectors.
Net Revenues Increased 10% to $137.1 million year-over-year. This reflects strong performance across diversified portfolios and industries.
Net Income Increased to $28 million or $0.55 per diluted share, compared to $26 million or $0.50 per diluted share in the prior year period. The increase was supported by better utilization and a strong realized rate increase.
EBITDA Increased 9% to $38.8 million, producing a margin of 28.3% of net revenues compared to $35.8 million or 28.6% of net revenues in the same period of 2024. The slight decrease in margin was due to costs associated with a managers meeting, partially offset by better utilization and a strong realized rate increase.
Billable Hours Approximately 376,000, an increase of 4% year-over-year. This was driven by recruiting and retention efforts.
Average Number of Technical Full-Time Equivalent Employees 976, up 3% year-over-year. This increase was due to recruiting and retention efforts.
Utilization 74.1%, up from 73.4% in the same period of 2024. This reflects improved operational efficiency.
Realized Rate Increase Approximately 6% for the third quarter compared to the same period a year ago. This is attributed to Exponent's premium position in the marketplace, unparalleled talent, and differentiated expertise.
Compensation Expense Increased 8% year-over-year after adjusting for gains and losses in deferred compensation. This includes a gain in deferred compensation of $7 million compared to $7.2 million in the third quarter of 2024.
Stock-Based Compensation Expense $5.3 million, compared to $5.5 million in the prior year period, reflecting a slight decrease.
Other Operating Expenses Increased 6% to $12.7 million. This includes depreciation and amortization expense of $2.5 million for the third quarter.
G&A Expenses Increased 44% to $7.7 million in the third quarter. The increase was primarily due to travel and meals associated with an in-person managers meeting, which did not occur in the prior year.
Interest Income Decreased to $2.3 million for the third quarter, driven by lower interest rates.
Capital Expenditures $2.7 million for the quarter.
Shareholder Distributions $15.1 million distributed through dividend payments and $40 million of common stock repurchased at an average price of $70.45.
Engineering and Other Scientific Segment Net Revenues Represented 84% of net revenues in the third quarter and increased 10%, driven by demand for risk management and asset integrity management services in the utility industry and disputes related to services in the energy, automotive, and medical device sectors.
Environmental and Health Segment Net Revenues Represented 16% of net revenues in the third quarter and increased 9%, due to an increase in regulatory consulting engagements in the chemicals industry.
Human-machine interaction studies: Improving demand trends in consumer electronics, particularly with human-machine interaction studies.
AI integration: Engaged in early-stage initiatives tied to transformative technologies, including AI integrated into safety-critical systems.
Safety-critical systems: Advancing work in evaluating human-machine interaction and safety-critical systems, including advanced medical devices, robotics, and autonomous vehicles.
Energy sector: Increased activity in generation, delivery, and storage due to energy transition initiatives, extreme weather events, and data center growth.
Transportation sector: Rising disputes regarding design and performance of advanced vehicle technologies.
Life sciences: Increased engagements involving complex medical devices focusing on product safety, quality, and performance.
Construction sector: Higher demand for expertise in addressing complex construction challenges and disputes.
Chemicals sector: Strong demand for regulatory consulting related to the impact of chemicals on human health and the environment.
Revenue growth: Net revenues increased by 10% year-over-year to $137.1 million in Q3 2025.
Employee growth: Average number of technical full-time equivalent employees increased by 3% year-over-year.
Utilization rate: Utilization rate improved to 74.1% in Q3 2025 from 73.4% in Q3 2024.
Stock repurchase program: Board approved a $100 million increase in the stock repurchase program.
Talent investment: Focused on recruiting and retention efforts to grow technical staff and foster leadership.
AI and transformative technologies: Positioned to help clients navigate technological disruptions, including AI and safety-critical systems.
Energy Sector Challenges: Increased activity in failure analysis for legacy systems and challenges with new technologies due to energy transition initiatives, extreme weather events, and rapid growth of data centers.
Transportation Sector Risks: Disputes regarding the design and performance of advanced vehicle technologies are becoming more prevalent and complex, with higher consequences of failure.
Life Sciences Sector Risks: Increased scrutiny of product safety, quality, and performance for complex medical devices.
Construction Sector Challenges: Increased demand related to complex construction challenges and disputes.
Consumer Electronics Sector Risks: Lower activity in consumer electronics, though improving demand trends are noted.
Artificial Intelligence Risks: Integration of AI into safety-critical systems introduces new high-consequence failure modes and increased complexity and risk.
Regulatory and Environmental Risks: Demand for regulatory consulting in the chemical sector related to the impact of chemicals on human health and the environment.
Operational Risks: Seasonal lower utilization in the fourth quarter due to holidays and vacations, and increased G&A expenses due to firm-wide meetings.
Revenue Growth: For the fourth quarter of 2025, revenues before reimbursements are expected to grow in the low to mid-single digits. For the full year 2025, revenue before reimbursements is expected to grow in the low single digits.
EBITDA Margin: For the fourth quarter of 2025, EBITDA is expected to be 26% to 27% of revenues before reimbursements. For the full year 2025, EBITDA is expected to be 27.4% to 27.65% of revenues before reimbursements.
Utilization: Utilization in the fourth quarter of 2025 is expected to be 68% to 70%, with full-year utilization expected to be approximately 72.5%.
Realized Rate Increase: The realized rate increase is expected to be 4% to 5% for the fourth quarter and full year 2025.
Capital Expenditures: Capital expenditures for the full year 2025 are expected to be $10 million to $12 million.
Tax Rate: The tax rate for the fourth quarter of 2025 is expected to be approximately 28%, with the full year 2025 tax rate expected to be 28.5%.
Stock-Based Compensation Expense: For the fourth quarter of 2025, stock-based compensation expense is expected to be $4.9 million to $5.2 million. For the full year 2025, it is expected to be $23.7 million to $24 million.
Other Operating Expenses: For the fourth quarter of 2025, other operating expenses are expected to be $12.7 million to $13.2 million. For the full year 2025, they are expected to be $49.5 million to $50 million.
G&A Expenses: For the fourth quarter of 2025, G&A expenses are expected to be $6.1 million to $6.6 million. For the full year 2025, they are expected to be $25 million to $25.5 million.
Interest Income: Interest income for the fourth quarter of 2025 is expected to be $1.5 million to $1.8 million.
Dividend Payments: Distributed $15.1 million to shareholders through dividend payments in the third quarter of 2025.
Stock Repurchase: Repurchased $40 million of common stock at an average price of $70.45 in the third quarter of 2025.
Stock Repurchase Program Expansion: Board approved a $100 million increase in the current stock repurchase program, in addition to the $21.6 million available for repurchases as of October 3, 2025.
The earnings call highlights strong financial performance with increased revenues, improved utilization, and a significant realized rate increase. Shareholder returns are robust with dividends and stock repurchases. The Q&A session reveals optimism in hiring and growth, with AI integration and proactive/reactive business strategies. Despite some uncertainties in regulatory environments and rate normalization, the overall sentiment is positive, driven by strong operational metrics and strategic initiatives.
The earnings call reveals several negative factors: softer demand in chemical regulation, increased tax rate, revenue headwind due to a shorter quarter, and a decline in net income and EBITDA. The Q&A section highlighted concerns about utilization and regulatory delays. Despite some positive aspects like shareholder returns and interest income, the overall sentiment is negative due to financial underperformance and unclear guidance, leading to a predicted stock price decline of -2% to -8% over the next two weeks.
The earnings call revealed several negative factors: flat revenue and net income decline, increased tax rate, and higher stock-based compensation affecting profitability. Utilization rates are expected to decline, and there are challenges in maintaining headcount. Shareholder returns through dividends and repurchases are positive, but not enough to offset financial concerns. The Q&A session highlighted uncertainties in proactive services and unclear management responses on guidance. The market cap suggests a moderate reaction, leading to a negative stock price prediction.
The earnings call reveals flat revenue and declining net income, EPS, and EBITDA, driven by increased expenses. The Q&A highlights concerns about utilization rates and demand softness, with unclear management responses. Despite shareholder returns via dividends and buybacks, increased tax rates, supply chain challenges, and regulatory scrutiny weigh heavily. The market cap of $4.8 billion suggests a moderate reaction, leading to a negative stock price prediction of -2% to -8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
